Center for Financial Planning Inc. Boosts Stake in Align Technology, Inc. $ALGN

Center for Financial Planning Inc. raised its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 133.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 516 shares of the medical equipment provider’s stock after acquiring an additional 295 shares during the period. Center for Financial Planning Inc.’s holdings in Align Technology were worth $98,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Redmond Asset Management LLC grew its position in Align Technology by 2.0% during the first quarter. Redmond Asset Management LLC now owns 2,769 shares of the medical equipment provider’s stock valued at $440,000 after acquiring an additional 54 shares during the period. Horizon Investments LLC boosted its position in shares of Align Technology by 6.2% in the first quarter. Horizon Investments LLC now owns 1,018 shares of the medical equipment provider’s stock worth $162,000 after buying an additional 59 shares during the period. Atria Investments Inc boosted its position in shares of Align Technology by 4.9% in the second quarter. Atria Investments Inc now owns 1,575 shares of the medical equipment provider’s stock worth $298,000 after buying an additional 74 shares during the period. IFP Advisors Inc boosted its position in shares of Align Technology by 5.7% in the second quarter. IFP Advisors Inc now owns 1,427 shares of the medical equipment provider’s stock worth $270,000 after buying an additional 77 shares during the period. Finally, Covestor Ltd boosted its position in shares of Align Technology by 18.8% in the first quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock worth $78,000 after buying an additional 78 shares during the period. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on ALGN shares. Weiss Ratings downgraded Align Technology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, October 8th. Wells Fargo & Company decreased their target price on Align Technology from $199.00 to $181.00 and set an “overweight” rating for the company in a research report on Thursday. UBS Group decreased their target price on Align Technology from $160.00 to $155.00 and set a “neutral” rating for the company in a research report on Thursday, October 16th. Mizuho decreased their target price on Align Technology from $210.00 to $170.00 and set an “outperform” rating for the company in a research report on Monday, October 13th. Finally, Morgan Stanley upped their target price on Align Technology from $142.00 to $154.00 and gave the stock an “equal weight” rating in a research report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Align Technology currently has an average rating of “Hold” and an average price target of $177.27.

Align Technology Stock Performance

Shares of ALGN opened at $137.88 on Friday. The company has a market capitalization of $9.99 billion, a P/E ratio of 26.72, a P/E/G ratio of 1.49 and a beta of 1.70. Align Technology, Inc. has a one year low of $122.00 and a one year high of $246.19. The stock has a 50-day moving average price of $133.23 and a 200 day moving average price of $161.81.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 EPS for the quarter, beating analysts’ consensus estimates of $2.38 by $0.23. The firm had revenue of $995.69 million during the quarter, compared to the consensus estimate of $980.75 million. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.Align Technology’s revenue for the quarter was up 1.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.35 earnings per share. Align Technology has set its Q4 2025 guidance at EPS. As a group, equities research analysts forecast that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology announced that its Board of Directors has initiated a stock buyback plan on Tuesday, August 5th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to buy up to 2% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.